About 21 results found for searched term "CP-10" (0.051 seconds)
Cat.No. | Name | Target |
---|---|---|
M2202 | CPI-0610 | Epigenetic Reader Domain |
Pelabresib | ||
CPI-0610 is a novel BET protein bromodomain inhibitor. | ||
M2899 | Orbifloxacin | Antibiotic |
CP-104354 | ||
Orbifloxacin is a synthetic broad-spectrum fluoroquinolone antibiotic. | ||
M3659 | Pimavanserin | 5-HT Receptor |
ACP-103 | ||
Pimavanserin is a selective serotonin 5-HT2A inverse agonist, with pIC50 and pKd of 8.73 and 9.3, respectively. | ||
M5369 | Fenclonine (4-Chloro-DL-phenylalanine) | 5-HT Receptor |
PCPA; CP-10188; 4-Chloro-DL-phenylalanine; p-Chlorophenylalanine | ||
Fenclonine (4-Chloro-DL-phenylalanine) is a selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin. Fenclonine (4-Chloro-DL-phenylalanine) acts pharmacologically to deplete endogenous levels of serotonin. | ||
M6628 | CP 809101 hydrochloride | Others |
CP 809101 hydrochloride is a potent and selective 5-HT 2C agonist. | ||
M7451 | UCPH 101 | Others |
UCPH 101 is a selective non-substrate EAAT1 inhibitor. | ||
M8041 | CP-101537 | MMP |
Cp-101537 is an MMP inhibitor, a candidate compound for the treatment of myocardial infarction, and an antibacterial compound. | ||
M8062 | CP-100356 monohydrochloride | BCRP/ABCG2/MXR/ABCP |
CP-100356 is a specific inhibitor of MDR1 (P-Gp), the protypical ABC transporter. | ||
M8076 | CP-101606 mesylate | Others |
CP-101606 mesylate (Traxoprodil mesylate) is a potent noncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors, selective for the NR2B subunit. | ||
M8116 | CP-105,696 | Leukotriene Receptor |
CP-105,696 is an orally active, potent and selective leukotriene B4 receptor (LTB4R) antagonist (IC50 against [3H]LTB4 = 5. | ||
M8215 | CP-101,606 | Others |
Traxoprodil (CP-101,606) is a potent noncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors, selective for the NR2B subunit. | ||
M8671 | UCPH-102 | Others |
UCPH-102 is a selective inhibitor of the Excitatory Amino Acid Transporter subtype-1 (EAAT1, GLAST) with an IC50 value of 420 nM for EAAT1 and >300 μM for EAAT2-5. | ||
M10084 | AMY-101 acetate | Complement System |
Cp40; AMY101 acetate | ||
AMY-101 acetate is a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM). | ||
M13701 | Gemcitabine elaidate | Others |
CP-4126; CO-101; Gemcitabine 5'-elaidate | ||
Gemcitabine elaidate (CP-4126) is lipophilic pro-drug of Gemcitabine. Gemcitabine elaidate is converted to Gemcitabine by esterases in order to be phosphorylated. Gemcitabine elaidate exhibits anti-tumor activity. | ||
M13702 | Gemcitabine elaidate hydrochloride | Others |
CP-4126 hydrochloride; CO-101 hydrochloride; Gemcitabine 5'-elaidate hydrochloride | ||
Gemcitabine elaidate (CP-4126) hydrochloride is lipophilic pro-drug of Gemcitabine. Gemcitabine elaidate hydrochloride is converted to Gemcitabine by esterases in order to be phosphorylated. Gemcitabine elaidate hydrochloride exhibits anti-tumor activity. | ||
M13873 | Pimavanserin hemitartrate | 5-HT Receptor |
ACP-103 hemitartrate | ||
Pimavanserin (ACP-103) hemitartrate is a potent 5-HT 2A receptor inverse agonist with pIC50 and pKi of 8.73 and 9.3, respectively. | ||
M14614 | ACP-105 | Androgen Receptor |
ACP-105 is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively. | ||
M14869 | CP-10 | PROTAC |
CP-10 is a PROTAC connected by ligands for Cereblon and CDK, with highly selective, specific, and remarkable CDK6 degradation (DC50=2.1 nM). | ||
M20725 | MCP110 | Ras |
MCP110 is an inhibitor of Ras/Raf-1 interaction. MCP110 disrupts the interaction of activated Ras with Raf and is potential for the treatment of human tumors. | ||
M22016 | CP-809101 | Others |
CP-809101 | ||
M49361 | Cpd10 | RIPK |
Cpd10 is a type II RIPK1 inhibitor that binds to the ATP site in the inactive conformation of the kinase. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.